The DOI matches its Crossref record; 112 of the 115 references it cites were found in a registry or an index.
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Open accessAbstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The receptors for LDL (LDLR) and transferrin receptor (TFR) are both endocytosed from the cell surface via clathrin-coated vesicles and transported through intracellular recycling pathways (14, 15, 16, 17, 18, 19, 20).”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Elevated LDL-C levels are linked to an increased risk of ASCVD,4,5”
From Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation (2025) · cites this paper as [5]
In the citing paper
“Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies the task of generating models (including human cells and organoids or rodents) to connect genotype to organismal phenotype; these have led to many critical insights into the biology of health and disease in humans98,99.”
From A brief history of human disease genetics (2020) · cites this paper as [98]
In the citing paper
“These data suggest that lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“An example is the J-shaped association between alcohol consumption and cardiovascular disease; there is now consensus that this apparent protective effect of moderate levels of consumption is artefactual, as discussed above.130”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“For example, a large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol75,130 is only prevalent in East Asian populations.”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“Mutations in LDLR cause familial hypercholesterolemia (FH), characterized by elevated levels of plasma LDL-C and increased risk of coronary heart disease (1).”
From Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor (2022) · cites this paper as [1]
In the citing paper
“Statins block cholesterol synthesis by suppressing HMG-CoA reductase91”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citation(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citation
Research works printed but not linked: 2
- Anitschkow, 1913, Ueber experimentelle cholesterinsteatose und ihre bedeutung für die entstehung einiger pathologischer prozesse, Zentralbl. Allg. Pathol. Anat., 24, 1
- Goldstein, 1982, Lipoprotein receptors: Genetic defense against atherosclerosis, Clin. Res., 30, 417
Cited by
Sorted by citations
Items 901–1,000 of 1,000
PCSK9-promoted LDLR degradation: Recruitment or prevention of essential cofactors?
Li, R., Zhang, C. X., Liu, J., & Zhang, D.-W. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100362 · Cited by 4
Sherratt, S. C. R., Libby, P., Bhatt, D. L., & Mason, R. P. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-41192-2_17 · Cited by 1
Yang, C., Peng, C., Huang, L., Chen, F. Y., Kuo, C., Wu, C., Hsia, T., & Lin, C.-Y. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i33.7951 · Cited by 1
Zhu, Q., Tan, Y., Zou, X., & Lu, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-49771-1 · Cited by 1
Lipids, Lipoproteins, and Cardiovascular Outcomes
Sakers, A. P., Mszar, R., & Soffer, D. E. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_9 · Cited by 1
Cholesin, a new hormone bridges intestinal cholesterol absorption and hepatic synthesis
Amadi, P. U., & Zhang, D. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae024 · Cited by 1
Development of Dyslipidemia in Atherosclerosis and Modern Approaches to its Treatment
Blagov, A. V., Sobenin, I. A., Sukhorukov, V. N., Glanz, V. Y., Pleshko, E. M., & Orekhov, A. N. (2024) · The Heart Surgery Forum · doi:10.59958/hsf.7341 · Cited by 1
Dihydrotanshinone I promotes LDL uptake by HepG2 cells through increasing LDLR level
Hu, D., Qi, L., Wang, L.-T., Jin, Y.-M., Yang, X.-X., Yin, H., Zhang, R., Huang, Y., Sheng, J., & Wang, X. (2024) · CyTA - Journal of Food · doi:10.1080/19476337.2024.2402842 · Cited by 1
The effect of blood lipids on the comorbidity of multiple large arachnoid granulations
Guo, Y., Wang, Z., Gao, M., Zhou, D., Ding, Y., Ji, X., & Meng, R. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02341-4 · Cited by 1
Mert, G. Ö., Mert, K. U., Başaran, Ö., Doğan, V., Rencüzoğulları, İ., Özlek, B., Çinier, G., Özlek, E., Biteker, M., Kayıkçıoğlu, M., et al. (2025) · Coronary Artery Disease · doi:10.1097/mca.0000000000001493 · Cited by 1
Hart, T. L., Kris‐Etherton, P. M., & Petersen, K. H. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.03.014 · Cited by 1
License to drive: Receptor-mediated ER exit of proteins and lipids
Wang, X., Li, T., Guo, Y., & Chen, X. (2025) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2025.102501 · Cited by 1
Renovascular Hypertension and Related Conditions
Watanabe, T., & Fan, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-3675-4_18 · Cited by 1
Kılıç-Erkek, Ö., Gündoğdu, G., & Bor-Küçükatay, M. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00175-9 · Cited by 1
Kumari, N., Shamkuwar, C. A., Motghare, V. M., & Dakhale, G. N. (2025) · Cureus · doi:10.7759/cureus.85457 · Cited by 3
Therapeutic potential of the annexin A family in atherosclerosis
Jarad, S., & Zhang, D. (2025) · Clinical and Translational Discovery · doi:10.1002/ctd2.70064 · Cited by 1
Ishii, Y., Matsunaga, Y., Akiyama, H., Shimizu, K., & Honda, H. (2025) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2025.09.002 · Cited by 1
Xiao, W., Hu, Y., Shao, L., Liu, J., Wang, D., & Li, H. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07639-3 · Cited by 1
Hu, F., Wu, R., Zhao, X., Zhao, Y.-K., Zhou, J., Hu, B., Li, A., & Sun, Y. (2025) · Translational Stroke Research · doi:10.1007/s12975-025-01367-9 · Cited by 3
Yasmeen, A., Syed, M. H., Khardali, A., Almansour, H. A., & Alshammari, T. M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1674331 · Cited by 1
Zhu, A., Masuda, R., Nitschke, P., Jia, G., Yan, J., Holmes, E. C., Nicholson, J. K., Wist, J., Bernal, A., & Loo, R. L. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00859 · Cited by 1
Nutrigenomics in Disease Prevention and Management
Kaila, N. H. J., Halami, P. M., & Muthukumar, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-12415-9_4 · Cited by 1
Cholesterol Metabolism: An Ally in the Development and Progression of Cervical Cancer
Martínez-Ramírez, I., Muñoz-Bello, J. O., Contreras‐Paredes, A., Parra-Hernández, E., Carrillo‐García, A., & Lizano, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020591 · Cited by 1
Ahmad, P., Ghali, E. N. H. K., & Alvi, S. S. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10349-1 · Cited by 1
SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicity
Zhong, Y., Mazik, L., Su, H., Chiang, C.-Y., Geng, F., Mo, X. M., Wang, Q., Kou, Y., Chen, W., Li, Z., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116896 · Cited by 3
Xiao, F. N., Norris, D. M., Yang, G., Li, Y. E., Brown, A. J., & Yang, H. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100989 · Cited by 2
Combination Lipid-Lowering Therapy After ACS: Should this be the New Standard of Care?
Brandts, J., & Marx, N. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02346-8 · Cited by 1
C/EBP α is Essential for Gonadal but Not Inguinal White Adipose Tissue Formation in Mice
Hu, K. Y., Ma, Y., Dodge, E. A., Maguire, O. A. B., Matias, C. V., Barney, R. P., Himede, H. S., Pardo, J. G., Cepeda, M., Gordon, S. M., et al. (2026) · Obesity · doi:10.1002/oby.70142 · Cited by 1
Li, M., Gu, W., Cao, L.-L., Chen, S., Duan, X., Xu, Y.-H., Wu, S.-L., & Yin, H.-Y. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120665 · Cited by 1
Sellam, M., Lambert, M., Varin‐Blank, N., & Saitoski, K. (2026) · Metabolites · doi:10.3390/metabo16020145 · Cited by 1
Mohamed, D. A., Elbakry, H. F. H., Gamil, I., Abdelgayed, S. S., & Mabrok, H. B. (2026) · Applied Biosciences · doi:10.3390/applbiosci5010017 · Cited by 1
Bragg, F., Alegre-Díaz, J., Trichia, E., Torres, J. M., Baca, P., Garcilazo‐Ávila, A., González-Carballo, C., Ramírez-Reyes, R., Rivas, F., Aguilar-Ramirez, D. J., et al. (2026) · Diabetes Care · doi:10.2337/dc25-2933 · Cited by 1
Tissue-selective COPII modulator SEC16B aggravates cardiovascular disease by promoting lipid export
Wang, X., Hu, Y. M., Liu, L., Huang, R., Wang, Y., Liu, B., Zhao, Y., Zhu, Y., Lv, J., Liu, L., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00754-8 · Cited by 1
Lu, W., Zhao, Z., Molina, D., Fan, H., Shi, R., Tian, Y., Gopoju, R., Yang, T., Zhang, X., Zhang, Y., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci204602 · Cited by 1
Chen, H., Zhao, M., Luo, Y., Chu, X., & Li, D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70448 · Cited by 1
Kheirkhah, A., Maio, S. D., Coassin, S., Schönherr, S., Lamina, C., Forer, L., Kronenberg, F., & Schachtl‐Riess, J. F. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101564 · Cited by 2
Chapman, M. J., Thérond, P., & Meikle, P. J. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109050 · Cited by 1
Phenolic Compounds with PCSK9 Secretion Inhibitory Activities from the Fruits of Liriope spicata
Zheng, R., Seo, M.-H., Park, C., Ryu, G. M., Huh, J., Choi, Y. H., Whang, W. K., & Chin, Y. (2026) · ACS Omega · doi:10.1021/acsomega.6c02002 · Cited by 1
Ahmad, P., Shah, A., Alvi, S. S., Chaturvedi, C. P., Ahmad, S., Sheeha, B. H. B., Puri, P., Alothamali, O. W., & Khan, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1781950 · Cited by 1
Translating Lipoprotein Genetics Into New Therapies
Hegele, R. A. (2026) · Circulation Research · doi:10.1161/circresaha.126.328828 · Cited by 1
Khattib, A., Shmet, M., Ashkar, R., Hayek, T., & Khatib, S. (2026) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001047 · Cited by 1
Luo, S., Ai, Y., Burgess, S., Yeung, S. L. A., & Ala‐Korpela, M. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120815 · Cited by 1
Wang, D., Tan, H., Peng, L., Wu, X., Gao, J., & Ma, W. (2026) · Biology · doi:10.3390/biology15120917 · Cited by 1
Zhuang, Y., Zhang, W., Zhou, L., Shu, H., Bo, W., Wang, Y., Huang, X., Zhao, X., Zheng, H., Guo, D., et al. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72053 · Cited by 1
Jarad, S., Gu, H., Huang, D., Amadi, P. U., Gill, G. S., Spaans, F., Chatha, A., Yousef, A., Graton, M. E., Patel, R. M., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70739 · Cited by 1
Reorganization of the slide helix by cholesterol during KirBac1.1 channel inactivation in membranes
Bysack, A., & Raghuraman, H. (2026) · The Journal of General Physiology · doi:10.1085/jgp.202614000 · Cited by 1
Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy
Averna, M., Hussain, M. M., & Norata, G. D. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01336-1 · Cited by 1
THE ROLE OF PXR AND IKKβ SIGNALING IN CARDIOMETABOLIC DISEASE
Helsley, R. N. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.040 · Cited by 1
Association between diabetes markers and cholesterol
Das, R. N. (2017) · Diabetes Management · Cited by 1
da Costa, L. F. T. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110500 · Cited by 1
New Perspectives in COPD Management
Yawn (2021) · The Journal of Family Practice · doi:10.12788/jfp.0220 · Cited by 1
Litwack, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85718-5.00004-2 · Cited by 1
Huff, M. W., & Rayner, K. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824048-9.00013-4 · Cited by 1
The metabolites derived from lipids and their effects on human health
Xiu, L., Hung, L.-S., Wang, L., Huang, J., & Wang, X. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823914-8.00004-5 · Cited by 2
Li, Y., Xie, J., Lu, B., Sun, X., Chen, F., Tong, Z., Sai, W.-W., Zhang, W., Wang, Z., & Zhong, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.911358 · Cited by 1
Bashir, B., Iqbal, Z., Schofield, J. D., & Soran, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00012-7 · Cited by 1
Computationally Modelling Cholesterol Metabolism and Atherosclerosis
Davies, C., Morgan, A. E., & Auley, M. T. M. (2023) · Biology · doi:10.3390/biology12081133 · Cited by 1
Wang, Z., Yelamanchili, D., Liu, J., Gotto, A. M., Rosales, C., Gillard, B. K., & Pownall, H. J. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100456 · Cited by 1
Ndagijimana, E., Nshimiyimana, A., Habyarimana, T., Izere, C., & Niyonzima, F. N. (2024) · East Africa Science · doi:10.24248/easci.v6i1.96 · Cited by 1
Wang, H.-Y., Nguyen, T. P., Sternisha, A. C., Carroll, C. L., Cross, B., Morlock, L., Williams, N. S., McBrayer, S. K., Nijhawan, D., & Brabander, J. K. D. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00402 · Cited by 1
Hassen, H., Škvorová, P., Pokhrel, K., Kulma, M., Piątkowska, E., Kostogrys, R. B., Kouřimská, L., Tarko, T., & Franczyk‐Żarów, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137256 · Cited by 2
Cheshire, M., & Akbar, U. A. (2024) · Cureus · doi:10.7759/cureus.68198 · Cited by 1
Prophylactic and therapeutic effects of EsV3 on atherosclerotic lesions in ApoE−/− mice
Wang, Y., Ohishi, H., Wu, R., Liu, H., & Xu, R. H. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04497-y · Cited by 1
Low-Dose Docetaxel Is Effective in Reducing Atherogenic Lipids and Atherosclerosis
Choi, H. Y., Ruel, I. L., Choi, S., Iatan, I., Choi, S., Lee, J., & Genest, J. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041484 · Cited by 2
Jeong, I., Kwon, H., Kim, D. J., & Kim, S. G. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2200 · Cited by 1
Lin, J., Yu, J., Huang, C., Lin, D., Li, F., Qi, Y., Liang, Y. S., Wang, C., Cai, L., Huang, Y., et al. (2025) · Aging · doi:10.18632/aging.206280 · Cited by 1
Cholesterol: A chemical of life and death
Haris, P. I. (2016) · Biomedical Spectroscopy and Imaging · doi:10.3233/bsi-160161 · Cited by 1
Mediterranean Diet for Active and Healthy Aging
Noreen, N., Shah, M. A., Khan, F., Niaz, K., Muhammad, F., Shah, I., & Abdollahi, M. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-3552-9_11 · Cited by 1
Cholesterol in virus entry into host cell: diet, phytosterols and statins
Montero, O. (2021) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v11i3.780 · Cited by 1
Addressing Nutritional Gaps: Simple Steps for the Primary Care Provider
Quan, Q. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0059 · Cited by 1
An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome
Lacy (2020) · The Journal of Family Practice · doi:10.12788/jfp.0060 · Cited by 1
Quek, D. K. (2021) · ASEAN heart journal · doi:10.31762/ahj2130.0101 · Cited by 1
Aronow, W. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.87280 · Cited by 1
Decision Points in the Management of Patients with Diabetic Kidney Disease
Weir (2021) · The Journal of Family Practice · doi:10.12788/jfp.0217 · Cited by 1
Utilizing CGM Ambulatory Glucose Profiles to Optimize Diabetes Management
Miller (2021) · The Journal of Family Practice · doi:10.12788/jfp.0226 · Cited by 1
Euphornin L promotes lipid clearance by dual regulation of LDLR and PCSK9
Li, H., Li, J., Zhang, X., Li, J., Xi, C., Wang, W.-Q., Lu, Y., & Xuan, L. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10817 · Cited by 1
Genetik menschlicher Erkrankungen
Graw, J. (2020) · Springer eBooks · doi:10.1007/978-3-662-60909-5_13 · Cited by 1
4 Chemistry of Waxes and Sterols
Parish, E. J., & Grainger, W. S. (2017) · CRC Press eBooks · doi:10.1201/9781315151854-5 · Cited by 1
The Great Cholesterol Quandary and Global Consciousness Awakening
Alabdulgader, A. (2023) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2023.1311064 · Cited by 1
Diop, A. B. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.53.008426 · Cited by 1
Hartwig, F. P., Borges, M. C., & Lawlor, D. A. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.310897 · Cited by 1
Tissue engineered micro and macrovasculature utilizing stromal vascular fraction.
Zakhari, J. S. (2018) · doi:10.18297/etd/2974 · Cited by 1
HCMV Manipulation of Host Cholesteryl Ester Metabolism
Dahlmann, E. A. (2019) · UA Campus Repository (The University of Arizona) · Cited by 1
Applying lipidomics strategies to study lipid metabolic diseases
Zhang, W. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.169407826 · Cited by 1
Cholesterol: a putative oncogenic driver for DLBCL
Russo, V. E. A. (2022) · Blood · doi:10.1182/blood.2021014300 · Cited by 1
Zhu, W., Huang, P., Li, R., Ran, J., Dai, W., Tang, Y., Lian, P., Ding, C., & Huang, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1890507/v1 · Cited by 1
Regulation of cellular LDL uptake by PROX1 and CHD7Preprint
Serrano-Zayas, C., Holding, M. L., Khan, T. G., Tang, V. T., Skidmore, J. M., Martin, D. M., Ginsburg, D., & Emmer, B. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.20.507601 · Cited by 1
Long-term mental health outcomes after SARS-CoV-2 infection: prospective cohort studyPreprint
Wang, Y., Xie, J., García‐Rizo, C., & Prieto‐Alhambra, D. (2022) · medRxiv · doi:10.1101/2022.09.26.22280293 · Cited by 1
Tesfa, E., Munshea, A., Nibret, E., Mekonnen, D. S., Sinishaw, M. A., & Gizaw, S. T. (2023) · Research Square · doi:10.21203/rs.3.rs-2404370/v1 · Cited by 1
Rebitzer, J. B., & Rebitzer, R. S. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197603109.003.0007 · Cited by 1
Alli‐Balogun, G. O., Ivanović, L., Kukulski, W., & Levine, T. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.08.552482 · Cited by 1
Mutailipu, M., Zhang, M., Ding, W., Fan, Y., Ye, Y., & Lu, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3338609/v1 · Cited by 1
Role of lysosome-associated membrane protein, Lamp1, in Drosophila melanogaster
Chaudhry, N. Y. (2023) · doi:10.31274/td-20240617-261 · Cited by 1
GPR182 is a lipoprotein receptor for dietary fat absorptionPreprint
Sun, Z., Torphy, R. J., Miller, E. N., Darehshouri, A., Vigil, I., Terai, T., Eleanor, E., Sun, Y., Guo, Y., Yee, E. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.634329 · Cited by 1
Yan, Z., & Guo, J. (2025) · medRxiv · doi:10.1101/2025.04.28.25326612 · Cited by 1
Ni, L., Zhao, X., Zheng, L., Shimizu, M., Sasaki, T., Sakurai, H., Sato, R., & Yamauchi, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690680 · Cited by 1
Tinoco, A., Li, C., Khurana, J. K., Jara, B. B., Plichta, D. R., Kenny, D. J., Xavier, R. J., & Balskus, E. P. (2025) · SSRN Electronic Journal · doi:10.64898/2025.12.29.696961 · Cited by 1
Ramakrishnan, V. M. (2015) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2319
Higgins, C. A., & Rees, A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000284
Macrophage Phenotypes in the Adipose Tissue of Postmenopausal Women
Králová, A., Lesná, I. K., Froněk, J., Čejková, S., Sekerková, A., Janoušek, L., Thieme, F., Střı́ž, I., Ždychová, J., & Poledne, R. (2015) · Physiological Research · doi:10.33549/physiolres.933150
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Goldstein, Joseph L.
- Brown, Michael S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 161
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4525717
- OpenAlex
- W2160347316
- Cited by
- 1,233
- References
- 115
- Citations by year
- 2026: 101 · 2025: 134 · 2024: 117 · 2023: 121 · 2022: 136 · 2021: 150 · 2020: 116 · 2019: 105 · 2018: 87 · 2017: 84 · 2016: 61 · 2015: 19
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Regeneron Pharmaceuticals
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- cholesterol, coronary artery disease, low-density lipoprotein, LDL receptor, LDLR mutations, familial hypercholesterolemia, statins, lipid-lowering therapy, atherosclerosis
- MeSH terms
- Animals, Cardiovascular Diseases, Cholesterol, Coronary Vessels, Dietary Fats, Humans, Receptors, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
